Some Epidermolysis Bullosa Acquisita Sera React with Epitopes Within the Triple-helical Collagenous Domain As Indicated by Immunoelectron Microscopy
Overview
Affiliations
Background: Epidermolysis bullosa acquisita (EBA) autoantibodies recognize epitopes predominantly within the N-terminal noncollagenous (NC)-1 domain of type VII collagen. Recently, some EBA cases with reactivity to other domains, i.e. the triple-helical (T-H) collagenous domain and the NC-2 domain, have been reported.
Objectives: To investigate the ultrastructural localization of epitopes for sera from five patients with EBA that were unreactive by immunoblotting with the NC-1, NC-2 and collagenous domains of type VII collagen.
Methods: Immunogold postembedding indirect immunoelectron microscopy was performed using normal human skin and type VII collagen-deficient skin as substrates.
Results: Postembedding indirect immunoelectron microscopy revealed that the five EBA sera showed immunoreactivity in the dermis, mainly located 0-400 nm below the lamina densa. IgG labelling was not observed in type VII collagen-deficient skin from a patient with recessive dystrophic epidermolysis bullosa. The distribution histogram found in this study was different from those of sera that reacted with the NC-1 and/or NC-2 domains, and was similar to those of sera reacting with the T-H collagenous domain.
Conclusions: Our results suggest that epitopes within the T-H collagenous domain of type VII collagen are recognized by IgG antibodies from some EBA sera. These antibodies appear to be found in patients with inflammatory-type EBA.
Epidermolysis Bullosa Acquisita: The 2019 Update.
Koga H, Prost-Squarcioni C, Iwata H, Jonkman M, Ludwig R, Bieber K Front Med (Lausanne). 2019; 5:362.
PMID: 30687710 PMC: 6335340. DOI: 10.3389/fmed.2018.00362.
Vorobyev A, Ujiie H, Recke A, Buijsrogge J, Jonkman M, Pas H J Invest Dermatol. 2015; 135(6):1565-1573.
PMID: 25689103 DOI: 10.1038/jid.2015.51.
Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.
Ludwig R ISRN Dermatol. 2013; 2013:812029.
PMID: 23956869 PMC: 3727188. DOI: 10.1155/2013/812029.
Licarete E, Ganz S, Recknagel M, Di Zenzo G, Hashimoto T, Hertl M BMC Immunol. 2012; 13:16.
PMID: 22471736 PMC: 3368718. DOI: 10.1186/1471-2172-13-16.